Neurocrine Biosciences
NBIX
#1394
Rank
โ‚ฌ12.07 B
Marketcap
119,29ย โ‚ฌ
Share price
1.39%
Change (1 day)
18.82%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

Neurocrine Biosciences (NBIX) - Total assets

Total assets on the balance sheet as of September 2024 : โ‚ฌ3.37 Billion

According to Neurocrine Biosciences 's latest financial reports the company's total assets are โ‚ฌ3.37 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Neurocrine Biosciences - Total assets on balance sheet (from 2001 to 2024)

Total assets by year

Year Total assets Change
2023-12-31โ‚ฌ2.94 B33.19%
2022-12-31โ‚ฌ2.20 B20.67%
2021-12-31โ‚ฌ1.83 B29.76%
2020-12-31โ‚ฌ1.41 B20.97%
2019-12-31โ‚ฌ1.16 B34.29%
2018-12-31โ‚ฌ0.86 B27.4%
2017-12-31โ‚ฌ0.68 B96.32%
2016-12-31โ‚ฌ0.34 B-20.07%
2015-12-31โ‚ฌ0.43 B117.3%
2014-12-31โ‚ฌ0.19 B78.41%
2013-12-31โ‚ฌ0.11 B-24.4%
2012-12-31โ‚ฌ0.14 B39.05%
2011-12-31โ‚ฌ0.10 B-1.87%
2010-12-31โ‚ฌ0.10 B119.66%
2009-12-31โ‚ฌ49.42 M-41.53%
2008-12-31โ‚ฌ84.53 M-55.38%
2007-12-31โ‚ฌ0.18 B-35.84%
2006-12-31โ‚ฌ0.29 B-27.59%
2005-12-31โ‚ฌ0.40 B6.55%
2004-12-31โ‚ฌ0.38 B-13.16%
2003-12-31โ‚ฌ0.44 B72.88%
2002-12-31โ‚ฌ0.25 B-34.98%
2001-12-31โ‚ฌ0.39 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
โ‚ฌ2.73 B-19.04%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ17.21 B 410.39%๐Ÿ‡ฌ๐Ÿ‡ง UK
โ‚ฌ10.25 M-99.70%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ72.15 B 2,038.81%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ136.86 B 3,957.20%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ209.44 B 6,108.66%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.87 B-73.95%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ7.08 M-99.79%๐Ÿ‡บ๐Ÿ‡ธ USA